GSK press releases Follow GSK and Alfasigma announce agreement on worldwide rights for linerixibat GSK and Alfasigma today announced a licence agreement under which Alfasigma will acquire worldwide exclusive rights to linerixibat https://www.gsk.com/en-gb/media/press-releases/gsk-and-alfasigma-announce-agreement/ gsk.com
